{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:29:40Z","timestamp":1793496580298,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.gim.2022.11.004","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T03:03:37Z","timestamp":1671159817000},"page":"100336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":195,"title":["Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)"],"prefix":"10.1016","volume":"25","author":[{"given":"Jeffrey S.","family":"Dungan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Klugman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Darilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassmine M.N.","family":"Akkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin G.","family":"Monaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Erwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.gim.2022.11.004_bib1","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"issue":"7","key":"10.1016\/j.gim.2022.11.004_bib3","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.gim.2022.03.019","article-title":"Systematic evidence-based review: the application of noninvasive prenatal screening using cell-free DNA in general-risk pregnancies","volume":"24","author":"Rose","year":"2022","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.gim.2022.11.004_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00006250-200701000-00054","article-title":"ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities","volume":"109","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"9360","key":"10.1016\/j.gim.2022.11.004_bib5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(03)12680-3","article-title":"Antenatal screening for Down\u2019s syndrome with the quadruple test","volume":"361","author":"Wald","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.siny.2013.11.013","article-title":"A\u00a0historical and practical review of first trimester aneuploidy screening","volume":"19","author":"Russo","year":"2014","journal-title":"Semin Fetal Neonatal Med"},{"issue":"19","key":"10.1016\/j.gim.2022.11.004_bib7","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa043693","article-title":"First-trimester or second-trimester screening, or both, for Down\u2019s syndrome","volume":"353","author":"Malone","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.gim.2022.11.004_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41436-021-01101-4","article-title":"Outcome of publicly funded nationwide first-tier noninvasive prenatal screening","volume":"23","author":"Van Den Bogaert","year":"2021","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.gim.2022.11.004_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","article-title":"TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands","volume":"105","author":"van der Meij","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gim.2022.11.004_bib10","author":"Hamilton"},{"key":"10.1016\/j.gim.2022.11.004_bib11","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.gim.2022.11.004_bib12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jclinepi.2015.11.017","article-title":"A\u00a0guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach","volume":"72","author":"Neumann","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib13","first-page":"447","article-title":"Age-specific detection and false-positive rates: an aid to counseling in Down syndrome risk screening","volume":"81","author":"Reynolds","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.gim.2022.11.004_bib14","first-page":"1043","article-title":"Age related detection and false positive rates when screening for Down\u2019s syndrome in the first trimester using fetal nuchal translucency and maternal serum free betahCG and PAPP-A","volume":"108","author":"Spencer","year":"2001","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.AOG.0000278570.76392.a6","article-title":"First- and second-trimester screening: detection of aneuploidies other than Down syndrome","volume":"110","author":"Breathnach","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gim.2022.11.004_bib16","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1097\/AOG.0000000000004084","article-title":"Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.gim.2022.11.004_bib17","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pd.2145","article-title":"Second-trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies","volume":"28","author":"Garchet-Beaudron","year":"2008","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib18","first-page":"276","article-title":"Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience","volume":"110","author":"Spencer","year":"2003","journal-title":"BJOG"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib19","first-page":"809","article-title":"Chromosomal mosaicism in human feto-placental development: implications for prenatal diagnosis","volume":"3","author":"Grati","year":"2014","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.gim.2022.11.004_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ajmg.10391","article-title":"Genetic counseling for sex chromosome abnormalities","volume":"110","author":"Linden","year":"2002","journal-title":"Am J Med Genet"},{"issue":"5","key":"10.1016\/j.gim.2022.11.004_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/pd.5044","article-title":"The benefits and limitations of cell-free DNA screening for 47, XXY (Klinefelter syndrome)","volume":"37","author":"Samango-Sprouse","year":"2017","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000098184","article-title":"X\u00a0chromosome loss and ageing","volume":"116","author":"Russell","year":"2007","journal-title":"Cytogenet Genome Res"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib23","doi-asserted-by":"crossref","first-page":"332.e1","DOI":"10.1016\/j.ajog.2014.11.041","article-title":"Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes","volume":"212","author":"Wapner","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gim.2022.11.004_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/uog.12464","article-title":"Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis","volume":"41","author":"Hillman","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.gim.2022.11.004_bib25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pd.4613","article-title":"Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies","volume":"35","author":"Grati","year":"2015","journal-title":"Prenat Diagn"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib26","doi-asserted-by":"crossref","first-page":"E802","DOI":"10.9778\/cmajo.20200294","article-title":"Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening","volume":"9","author":"Blagojevic","year":"2021","journal-title":"CMAJ Open"},{"issue":"7","key":"10.1016\/j.gim.2022.11.004_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253866","article-title":"Have maternal or paternal ages any impact on the prenatal incidence of genomic copy number variants associated with fetal structural anomalies?","volume":"16","author":"Larroya","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.gim.2022.11.004_bib28","doi-asserted-by":"crossref","first-page":"79.e1","DOI":"10.1016\/j.ajog.2022.01.002","article-title":"Cell-free DNA screening for prenatal detection of 22q11.2 deletion syndrome","volume":"227","author":"Dar","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.gim.2022.11.004_bib29","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1080\/14767058.2019.1647161","article-title":"Cell-free fetal DNA screening for detection of microdeletion syndromes: a cost-effectiveness analysis","volume":"34","author":"Avram","year":"2021","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"23","key":"10.1016\/j.gim.2022.11.004_bib30","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","article-title":"Chromosomal microarray versus karyotyping for prenatal diagnosis","volume":"367","author":"Wapner","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.gim.2022.11.004_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/a-1226-6538","article-title":"Cell-free DNA testing in routine practice: characterisation of a cohort with positive results for trisomies, sex chromosome anomalies and microdeletions","volume":"81","author":"Tekesin","year":"2021","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"6","key":"10.1016\/j.gim.2022.11.004_bib32","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1002\/mgg3.674","article-title":"Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing","volume":"7","author":"Yu","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.gim.2022.11.004_bib33","series-title":"Chromosome Abnormalities and Genetic Counseling","first-page":"439","article-title":"Chromosome abnormalities detected at prenatal diagnosis","author":"Gardner","year":"2012"},{"issue":"2","key":"10.1016\/j.gim.2022.11.004_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41436-019-0630-y","article-title":"Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA","volume":"22","author":"Grati","year":"2020","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1097-0223(199703)17:3<201::AID-PD56>3.0.CO;2-H","article-title":"Rare trisomy mosaicism diagnosed in amniocytes, involving an autosome other than chromosomes 13, 18, 20, and 21: karyotype\/phenotype correlations","volume":"17","author":"Hsu","year":"1997","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.gim.2022.11.004_bib36","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/AOG.0000000000000275","article-title":"Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures","volume":"123","author":"Larion","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.gim.2022.11.004_bib37","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jogc.2019.12.007","article-title":"Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions in average-risk pregnancies: a cost-effectiveness analysis","volume":"42","author":"Xie","year":"2020","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"24","key":"10.1016\/j.gim.2022.11.004_bib38","first-page":"2905","article-title":"First trimester contingent screening for trisomies 21,18,13: is this model cost efficient and feasible in public health system?","volume":"30","author":"Colosi","year":"2017","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"9","key":"10.1016\/j.gim.2022.11.004_bib39","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jogc.2017.01.025","article-title":"Enhanced first trimester screening for trisomy 21 with contingent cell-free fetal DNA: a comparative performance and cost analysis","volume":"39","author":"Huang","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"4","key":"10.1016\/j.gim.2022.11.004_bib40","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2021.06.079","volume":"225","author":"Prabhu","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.gim.2022.11.004_bib41","doi-asserted-by":"crossref","first-page":"417.e1","DOI":"10.1016\/j.ajog.2021.04.212","article-title":"Obesity and no call results: optimal timing of cell-free DNA testing and redraw","volume":"225","author":"Hopkins","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"17","key":"10.1016\/j.gim.2022.11.004_bib42","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa1407349","article-title":"Cell-free DNA analysis for noninvasive examination of trisomy","volume":"372","author":"Norton","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.gim.2022.11.004_bib43","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1038\/s41431-019-0443-0","article-title":"Prospective head-to-head comparison of accuracy of two sequencing platforms for screening for fetal aneuploidy by cell-free DNA: the PEGASUS study","volume":"27","author":"Rousseau","year":"2019","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10.1016\/j.gim.2022.11.004_bib44","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/pd.5152","article-title":"The association between anticoagulation therapy, maternal characteristics, and a failed cfDNA test due to a low fetal fraction","volume":"37","author":"Burns","year":"2017","journal-title":"Prenat Diagn"},{"issue":"6","key":"10.1016\/j.gim.2022.11.004_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2021.100466","article-title":"The impact of maternal autoimmune disease on cell-free DNA test characteristics","volume":"3","author":"MacKinnon","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib46","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41436-020-01009-5","article-title":"High-throughput fetal fraction amplification increases analytical performance of noninvasive prenatal screening","volume":"23","author":"Welker","year":"2021","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.gim.2022.11.004_bib47","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/pd.6028","article-title":"Association between low fetal fraction in cell-free DNA testing and adverse pregnancy outcome: a systematic review","volume":"41","author":"Scheffer","year":"2021","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1016\/j.gim.2022.11.004_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/pd.5609","article-title":"Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening","volume":"40","author":"Hedriana","year":"2020","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1016\/j.gim.2022.11.004_bib49","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/pd.4666","article-title":"Recommended pre-test counseling points for noninvasive prenatal testing using cell-free DNA: a 2015 perspective","volume":"35","author":"Sachs","year":"2015","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.gim.2022.11.004_bib50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/uog.22119","article-title":"Optimal timing of fetal reduction from twins to singleton: earlier the better or later the better?","volume":"57","author":"Zemet","year":"2021","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.gim.2022.11.004_bib51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev-genom-090314-050000","article-title":"Noninvasive prenatal genetic testing: current and emerging ethical, legal, and social issues","volume":"16","author":"Minear","year":"2015","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"4","key":"10.1016\/j.gim.2022.11.004_bib52","first-page":"1","article-title":"Noninvasive prenatal testing for trisomies 21, 18, and 13, sex chromosome aneuploidies, and microdeletions: a health technology assessment","volume":"19","year":"2019","journal-title":"Ont Health Technol Assess Ser"},{"issue":"5","key":"10.1016\/j.gim.2022.11.004_bib53","first-page":"1","article-title":"Perspectives of pregnant people and clinicians on noninvasive prenatal testing: a systematic review and qualitative meta-synthesis","volume":"19","author":"Vanstone","year":"2019","journal-title":"Ont Health Technol Assess Ser"},{"issue":"7","key":"10.1016\/j.gim.2022.11.004_bib54","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gim.2022.11.004_bib55","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11912-020-0862-7","article-title":"Pregnancy and cancer: the INCIP project","volume":"22","author":"Maggen","year":"2020","journal-title":"Curr Oncol Rep"},{"issue":"22","key":"10.1016\/j.gim.2022.11.004_bib56","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.21.02260","article-title":"Noninvasive prenatal test results indicative of maternal malignancies: a nationwide genetic and clinical follow-up study","volume":"40","author":"Heesterbeek","year":"2022","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.gim.2022.11.004_bib57","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/AOG.0000000000002474","article-title":"Maternal malignancy evaluation after discordant cell-free DNA results","volume":"131","author":"Carlson","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gim.2022.11.004_bib58","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/PO.20.00429","article-title":"Cancer diagnoses following abnormal noninvasive prenatal testing: a case series, literature review, and proposed management model","volume":"5","author":"Dow","year":"2021","journal-title":"JCO Precis Oncol"},{"issue":"6","key":"10.1016\/j.gim.2022.11.004_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000491750","article-title":"Clinical and economic impact of adopting noninvasive prenatal testing as a primary screening method for fetal aneuploidies in the general pregnancy population","volume":"45","author":"Kostenko","year":"2019","journal-title":"Fetal Diagn Ther"}],"updated-by":[{"DOI":"10.1016\/j.gim.2023.100874","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000}}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022010048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360022010048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T06:29:45Z","timestamp":1715408985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360022010048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1098360022010048"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2022.11.004","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Medical Genetics and Genomics. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100336"}}